Insider Trading History of Jacobson Paul F

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Jacobson Paul F since 2005. This trader's CIK number is 1250277. At the time of last reporting, Jacobson Paul F was the Chief Executive Officer of Thorne Healthtech, Inc.. (stock ticker symbol THRN). Also see all insider trading activities at Thorne Healthtech, Inc..

Note that in the past JACOBSON PAUL F also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Progenics Pharmaceuticals Inc (PGNX) by Jacobson Paul F

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2008 PGNX 0 $0 72,500 $737,975 10,000 $68,820
2005 PGNX 0 $0 3,000 $59,550 0 $0

Yearly summary of insider trading at Thorne Healthtech, Inc. (THRN) by Jacobson Paul F

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2022 THRN 0 $0 0 $0 50,000 $67,400


Insider trading activities at 2 companies by Jacobson Paul F:

1. Progenics Pharmaceuticals Inc (PGNX)

2. Thorne Healthtech, Inc. (THRN)

Table 1. Insider trading of Progenics Pharmaceuticals Inc (PGNX) by Jacobson Paul F

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2008-10-23 PGNX Sale 27,000 9.05 244,458
2008-10-22 PGNX Sale 35,500 9.38 333,167
2008-07-15 PGNX Sale 10,000 16.04 160,350
2008-07-15 PGNX Option Ex 10,000 6.88 68,820
2005-06-20 PGNX Sale 3,000 19.85 59,550

Table 2. Insider trading of Thorne Healthtech, Inc. (THRN) by Jacobson Paul F

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2022-03-31 THRN Option Ex 50,000 1.35 67,400

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Jacobson Paul F (Chief Executive Officer of Thorne Healthtech, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.